Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy ® for applications in early disease detection and precision medicine, today announced a first closing of $27 million (circa £22 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback